摘要
背景:效应 出现在作为痴呆研究进展的多数痴呆测评工具中,对于或多或少考虑到植物人状态病人的深入评估是不合理的 。目的:为了开发一种适用于评估晚期痴呆病人的调查问卷(Gatos 临床测试-GCT)。方法:本项研究包括各种原因导致的500例痴呆病人及其MMSE得分在0-2之间。由14种封闭式问题组成的GCT回答了利开特矢量表。总得分用来评估病人的痴呆程度。多种方面的信度和效度(包括表面、内容和结构效度及重测信度)进行了检测。结果:定义了“Autonomy/Alertness”,、“Gnosias” 和 “Somatokinetic function”三种量表,其克隆巴赫系数分别为0.851,、0.756 和0.598。与MMSE得分为0的那些病人相比,MMSE得分为1-2的GCT量表及其总分较高,有显著统计学意义(p<0.005)。GCT总得分小于12.5的病人有75%的可能是MMSE得分为0。结论:测验重度痴呆病人的”GATOS”问卷是有效的和可靠的,旨在确定这些病人能够维持一些生活质量。它是一种相对简短容易的实施工具。由于痴呆患病率预期在全世界范围内会进一步上升,我们相信GCT可以为健康的专业人士、护理人员和病人提供有价值的服务。
关键词: 痴呆,晚期的,调查表,可靠性,有效性
Current Alzheimer Research
Title:End-Stage Dementia Spark of Life: Reliability and Validity of the “GATOS” Questionnaire
Volume: 12 Issue: 2
Author(s): Gregory Tsoucalas, Stamati Bourelia, Vaso Kalogirou, Styliani Giatsiou, Eirini Mavrogiannaki, Georgios Gatos, Antonis Galanos, Olga Repana, Eleni Iliadou, Antonis Antoniou, Markos Sgantzos and Konstantinos Gatos
Affiliation:
关键词: 痴呆,晚期的,调查表,可靠性,有效性
摘要: Background: Fl oor effects are present in most dementia assessment tools as dementia progresses and the in–depth assessment of patients considered more or less on vegetative state is questionable. Objective: To develop a questionnaire (the “Gatos Clinical Test-GCT”) for the assessment of end-stage demented patients. Methods: Five hundred patients with dementia of various causes and an MMSE score between 0 and 2 were enrolled in the study. The GCT consists of 14 closed type questions rated on a Likert scale. The total score is used to evaluate patient’s dementia. Various aspects of validity and reliability (including face, content and structural validity as well as test-retest reliability) were examined. Results: Three subscales “Autonomy/Alertness”, “Gnosias” and “Somatokinetic function” were defined, with a Cronbach equal to 0.851, 0.756 and 0.598 respectively. The GCT subscales and total score were statistically significant higher in patients with MMSE score 1 or 2 compared with those with MMSE score 0 (p<0.0005). Patients with GCT total score less than 12.5 had 75% probability to have zero MMSE score. Conclusion: The “GATOS” questionnaire is a valid and reliable test for patients with severe dementia, aiming at identification of those patients who could sustain some quality of life. It is a relatively short and easy to administer tool. As dementia prevalence is expected to rise further worldwide we believe that GCT could offer valuable services to health professionals, caregivers and patients.
Export Options
About this article
Cite this article as:
Gregory Tsoucalas , Stamati Bourelia , Vaso Kalogirou , Styliani Giatsiou , Eirini Mavrogiannaki , Georgios Gatos , Antonis Galanos , Olga Repana , Eleni Iliadou , Antonis Antoniou , Markos Sgantzos and Konstantinos Gatos , End-Stage Dementia Spark of Life: Reliability and Validity of the “GATOS” Questionnaire, Current Alzheimer Research 2015; 12 (2) . https://dx.doi.org/10.2174/1567205012666150204122635
DOI https://dx.doi.org/10.2174/1567205012666150204122635 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Complex Actions of Statins in Brain and their Relevance for Alzheimer`s Disease Treatment: An Analytical Review
Current Alzheimer Research A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease
Current Drug Targets The Crosstalk Between miRNA and Mammalian Circadian Clock
Current Medicinal Chemistry Neuropeptides and Other Chemical Mediators, and the Role of Anti-inflammatory Drugs in Primary Headaches
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Aluminofluoride Complexes: Phosphate Analogues and a Hidden Hazard for Living Organisms
Current Inorganic Chemistry (Discontinued) Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer's Disease and Other Tauopathies
Current Drug Delivery Effect of Drugs in Cells and Tissues by NMR Spectroscopy
Current Topics in Medicinal Chemistry Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders
CNS & Neurological Disorders - Drug Targets Editorial [ Medicines Da Vinci Code: Deciphering the Intricate Origins of Clinical Neurovascular Pathology K. Maiese ]
Current Neurovascular Research Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets AICD Nuclear Signaling and Its Possible Contribution to Alzheimers Disease
Current Alzheimer Research Editorial: Thematic Issue-Topic–Diabetic Cardiovascular Disease–An Unmet Medical Need: Emerging Targets and Therapies-Introduction to the Special Issue
Cardiovascular & Hematological Agents in Medicinal Chemistry Polymeric Materials and Formulation Technologies for Modified-Release Tablet Development
Mini-Reviews in Medicinal Chemistry Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Focusing on New Monoamine Oxidase Inhibitors: Differently Substituted Coumarins As An Interesting Scaffold
Current Topics in Medicinal Chemistry Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease
Current Alzheimer Research Commentary (Research Highlights: Wnt-Signalling: A New Direction for Alzheimer Disease?)
CNS & Neurological Disorders - Drug Targets Role of Dietary Polyphenols in Attenuating Brain Edema and Cell Swelling in Cerebral Ischemia
Recent Patents on CNS Drug Discovery (Discontinued) Relationship between Inflammatory Mediators, Aβ Levels and ApoE Genotype in Alzheimer Disease
Current Alzheimer Research Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development
Current Topics in Medicinal Chemistry